Telehealth Prescribing Laws for GLP-1s by State: Where Rules Are Tightest

Telehealth prescribing isn't governed by a single federal law — it's a patchwork of 50 state regulatory frameworks, each with its own rules about what can be prescribed virtually, who can prescribe it, and what clinical standards must be met. For GLP-1 patients, these differences can determine whether you can access telehealth treatment at all, and what that treatment looks like.

The Federal Framework: Surprisingly Permissive

At the federal level, the regulatory environment for GLP-1 telehealth is relatively straightforward. GLP-1 medications are not controlled substances (they're not scheduled by the DEA), which means they're not subject to the special federal restrictions that apply to telehealth prescribing of opioids, stimulants, or benzodiazepines.

The Ryan Haight Act, which restricts online prescribing of controlled substances, does not apply to GLP-1 medications. This means that, from a federal perspective, a licensed provider can prescribe semaglutide or tirzepatide through a telehealth encounter without the in-person evaluation requirement that applies to controlled substances.

However, federal permissiveness is overridden by state law where state law is more restrictive. And several states have added requirements that go beyond the federal baseline.

States With the Tightest Telehealth Prescribing Rules

While the landscape shifts frequently as states update their telehealth statutes, several states have historically maintained stricter requirements for telehealth prescribing:

States requiring an initial in-person visit: Some states require a provider to conduct at least one in-person examination before establishing a prescribing relationship, even for non-controlled medications. After the initial in-person visit, follow-up can often shift to telehealth. These requirements were relaxed in many states during the COVID-19 pandemic but have been reimposed in some jurisdictions.

States with strict prescriber-patient relationship requirements: Several states define the provider-patient relationship more conservatively, requiring more extensive evaluation than a brief questionnaire-based encounter would satisfy.

States restricting NP/PA prescriptive authority: In some states, nurse practitioners or physician assistants have limited or supervised prescriptive authority, which can affect telehealth platforms that rely heavily on mid-level providers.

How Interstate Compacts Affect GLP-1 Telehealth

The Interstate Medical Licensure Compact (IMLC) has significantly expanded telehealth access by creating a streamlined pathway for physicians to obtain licenses in multiple states. As of 2026, 41 states and territories participate in the compact.

For GLP-1 patients, this means that larger telehealth platforms can more easily employ providers licensed in your state, reducing the geographic barrier to care. However, compact participation doesn't override individual state prescribing requirements — a compact-licensed physician still must follow the prescribing laws of the state where the patient resides.

What This Means for Your GLP-1 Access

Practically speaking, most patients in most states can access GLP-1 medications through legitimate telehealth platforms. The key variables are:

• Whether your state requires video (synchronous) consultation — some states accept audio-only or asynchronous evaluation, while others require real-time video
• Whether your state requires an initial in-person visit — this affects whether you can start treatment entirely online
• Whether your provider is licensed in your state — the most fundamental and non-negotiable requirement
• Whether your state has specific telehealth prescribing requirements for certain medication classes

Rural and Underserved Access

Telehealth's greatest promise is expanding access to patients in areas with limited local healthcare options. For GLP-1 patients in rural communities, telehealth may be the only practical path to an obesity medicine specialist or endocrinologist. Some states have recognized this and created telehealth-friendly provisions specifically for underserved areas, including relaxed in-person visit requirements and expanded scope of practice for mid-level providers.